Gene · 5598
Papers3,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,971
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Stiff Side of Cancer: How Matrix Mechanics Rewrites Non-Coding RNA Expression Programs. | Noncoding RNA | 2026 | 41745140 | PubTator, text mining | PubMed |
| The Gut-Prostate Axis: Decoding the Interplay of Environmental Factors, Microbial Metabolites, and Hormonal Regulation in Prostate Cancer Pathogenesis. | Technol Cancer Res Treat | 2026 | 41744425 | PubTator, text mining | PubMed |
| Benchmarking EGF signaling pathway inference using phosphoproteomics and kinase-substrate interactions. | Nat Commun | 2026 | 41741430 | PubTator, text mining | PubMed |
| Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat. | Curr Obes Rep | 2026 | 41739363 | PubTator, text mining | PubMed |
| The TPx protein of Taenia solium metacestode regulates Treg and Th17 cell differentiation via the TGF-β/Smad signaling pathway. | Front Immunol | 2026 | 41727496 | PubTator, text mining | PubMed |
| Discovery of Novel ERK5 Inhibitors for Pancreatic Cancer via a Virtual Screening Approach. | ACS Med Chem Lett | 2026 | 41704363 | PubTator, text mining | PubMed |
| Dissecting Context-Specific Effects of ERK5 Signaling in Triple-Negative Breast Cancer. | Cancers (Basel) | 2026 | 41681849 | PubTator, text mining | PubMed |
| Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth. | Cell Commun Signal | 2026 | 41634806 | PubTator, text mining | PubMed |
| Exploring the Shared Diagnostic Biomarkers and Molecular Mechanisms Related to Mitochondrial Dysfunction in Inflammatory Bowel Disease and Rheumatoid Arthritis. | Curr Issues Mol Biol | 2026 | 41614919 | PubTator, text mining | PubMed |
| Bacterial cell envelope components of gut commensals: effects in host-microbe interaction. | Ann Med | 2026 | 41614625 | PubTator, text mining | PubMed |
| A versatile platform for sequential glyco-, phospho-, and proteomics with multi-PTMs integration. | Nat Commun | 2026 | 41605919 | PubTator, text mining | PubMed |
| Protocatechuic Acid, a Gut-Derived Dietary Metabolite, Attenuates Endothelial Dysfunction via GPER-Mediated NO Signaling. | J Agric Food Chem | 2026 | 41605862 | PubTator, text mining | PubMed |
| Insights into RAS-driven melanoma and its therapeutic implications. | Cancer Treat Rev | 2026 | 41576808 | PubTator, text mining | PubMed |
| Novel 5,7-Diazaindole-based ERK5 inhibitor induces endoplasmic reticulum stress and mitochondrial apoptosis in non-small cell lung Cancer. | Bioorg Chem | 2026 | 41570587 | PubTator, text mining | PubMed |
| The role of metformin in extracellular matrix-based three-dimensional cell culture Models: A mini-review on therapeutic potentials. | Biochem Biophys Rep | 2026 | 41561225 | PubTator, text mining | PubMed |
| Translational evaluation of BUB1B as a precision medicine biomarker for hepatocellular carcinoma. | Sci Rep | 2026 | 41545558 | PubTator, text mining | PubMed |
| Cancer cachexia: molecular basis and therapeutic advances. | Signal Transduct Target Ther | 2026 | 41526343 | PubTator, text mining | PubMed |
| Machine learning-guided discovery of mitogen-activated protein kinase 7 (MAPK7 inhibitors): integrating virtual screening, docking, and molecular dynamics simulations. | In Silico Pharmacol | 2026 | 41522701 | PubTator, text mining | PubMed |
| Erk5-mediated microglial ferroptosis drives ischemic white matter damage via the Nfatc4-Clptm1l axis. | Proc Natl Acad Sci U S A | 2026 | 41512030 | PubTator, text mining | PubMed |
| Paeoniflorin promotes therapeutic senescence in melanoma through endoplasmic reticulum stress and the calpain1/ERK5/p27 axis. | Phytomedicine | 2026 | 41456525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5598/papers?page=3